UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017331
Receipt number R000020108
Scientific Title Study in current status and prognosis in patients with peripheral artery disease (Showa PAD registry)
Date of disclosure of the study information 2015/04/29
Last modified on 2023/05/11 15:46:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study in current status and prognosis in patients with peripheral artery disease (Showa PAD registry)

Acronym

Showa PAD registry

Scientific Title

Study in current status and prognosis in patients with peripheral artery disease (Showa PAD registry)

Scientific Title:Acronym

Showa PAD registry

Region

Japan


Condition

Condition

Peripheral artery disease

Classification by specialty

Medicine in general Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To analyse the current status and prognosis in peripheral artery disease

Basic objectives2

Others

Basic objectives -Others

A multicenter epidemiology observational study to determine the frequency of the event about the characteristics of the patients group with PAD and the health and distribution and a factor to affect

Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

All-cause death, cardiac death, cardiovascular death, non-cardiac death, non-cardiovascular death, admission (heart failure, myocardial infarction, cerebral infarction, critical limb ischemia), limb amputation

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Ankle brachial index (ABI) <1.0
Toe brachial index (TBI) <0.6
Skin purfusion pressure (SPP) <60mmHg

Key exclusion criteria

1) Patients once registered in this study
2) Patients unable to follow up
3) Patietns with poor prognosis with cancer
4) Patietns doctors decide not eligible
5) ABI, TBI, SPP were not met the criteria after recanalization therapy

Target sample size

700


Research contact person

Name of lead principal investigator

1st name Hiroshi
Middle name
Last name Suzuki

Organization

Showa Univeristy Fujigoka Hospital

Division name

Department of Cardiology

Zip code

227-8501

Address

1-30 Fujigaoka, Aoba-ku, Yokohama, Kanagawa

TEL

0459711151

Email

hrsuzuki@med.showa-u.ac.jp


Public contact

Name of contact person

1st name Hiroshi
Middle name
Last name Suzuki

Organization

Showa Univeristy Fujigoka Hospital

Division name

Department of Cardiology

Zip code

227-8501

Address

1-30 Fujigaoka, Aoba-ku, Yokohama 227-8501, Kanagawa, Jaoan

TEL

81-45-971-1151

Homepage URL


Email

hrsuzuki@med.showa-u.ac.jp


Sponsor or person

Institute

Showa Univeristy Fujigoka Hospital

Institute

Department

Personal name



Funding Source

Organization

Showa Univeristy Fujigoka Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Showa University Fujigaoka Hospital

Address

1-30 Fujigaoka, Aoba-ku, Yokohama, Kanagawa

Tel

0459711151

Email

hrsuzuki@med.showa-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

昭和大学藤が丘病院(神奈川県)、昭和大学病院(東京都)


Other administrative information

Date of disclosure of the study information

2015 Year 04 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

100

Results


Results date posted


Results Delayed

Delay expected

Results Delay Reason

Input of data delays.

Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 10 Month 01 Day

Date of IRB

2014 Year 10 Month 01 Day

Anticipated trial start date

2014 Year 10 Month 01 Day

Last follow-up date

2019 Year 09 Month 30 Day

Date of closure to data entry

2023 Year 03 Month 31 Day

Date trial data considered complete

2023 Year 03 Month 31 Day

Date analysis concluded

2023 Year 03 Month 31 Day


Other

Other related information

(1) All-cause death (2) Cardiac death (3) Cardiovascular death (4) Non-cardiac death (5) Non-cardiovascular death (6) Admission in heart failure (7) Admission in myocardial infarction (8) Admission in cerebral infarcition (9) Admission in critical limb ischemia (10) Limb amputation


Management information

Registered date

2015 Year 04 Month 29 Day

Last modified on

2023 Year 05 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020108


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name